Clinical Trial Update: A Study of RC118 Plus Toripalimab / RC148 in Patients with Locally Advanced Unresectable or Metastatic Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Ongoing Phase 1/2 clinical trial of RC118 plus toripalimab or RC148 in locally advanced unresectable or metastatic solid tumors; recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• RC118 (RC118)
• RC148 (RC148)
• Toripalimab (Toripalimab)

Snippet

Sponsor: RemeGen Co., Ltd. | Conditions: Advanced Solid Tumor | Phase 1, Phase 2 | Status: RECRUITING